KP Tissue Stock Technical Analysis

KPT Stock  CAD 10.86  -0.11  -1.00%   
As of the 20th of March, KP Tissue is marked at 10.86 per share. Recent trend indicators show Standard Deviation of 0.802, market risk adjusted performance of 0.4985, and Mean Deviation of 0.5813. Trend analytics rely on normalized volatility and volume metrics. Trend metrics are reviewed within historical sector ranges.

KP Tissue Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as KPT, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to KPT
  
KP Tissue's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
KP Tissue intrinsic value attempts to capture underlying worth, separate from current trading levels. For KP Tissue, key inputs include a P/B ratio of 1.57, and ROE of 5.55%. The quoted KP Tissue price is the exchange level where supply meets demand. The information is analytical in nature and is not intended as a specific recommendation.

What if' Analysis

Historical what-if analysis for KP Tissue is useful because it converts abstract timing questions into a structured review of past performance under changing entry and holding periods. The real value is perspective: it shows whether the thesis would have remained investable across different historical windows or depended too heavily on one favorable stretch.
0.00
12/20/2025
 
No Change 0.00  0.0 
In 3 months and 1 day
 
03/20/2026
0.00
An initial  0.00  allocation to KP Tissue on December 20, 2025 held through today would generate 0.00 in overall return. That corresponds to a 0.0% cumulative return in KP Tissue in aggregate over 90 days. All values are computed from publicly available trading activity and price records. The dataset is presented as structured reference material for independent review. The competitive set for KP Tissue includes Organto Foods, Pesorama, Swiss Water, and Big Rock. Comparative context is available through the listed peers. KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of dispo... More

Upside and Downside Indicators for KP Tissue Summary

For KP Tissue, these indicators describe the distribution of price movement across recent upside and downside ranges. The readings reflect recent momentum relative to observed price ranges.

KP Tissue Volatility and Risk Indicators Overview

Market risk indicators summarize volatility and return dispersion for KP Tissue. The signals are informational and describe volatility patterns. Values are drawn from observed market activity across periods. This view summarizes available data without implying outcomes.
The degree to which KP Tissue's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
Hype
Prediction
LowEstimatedHigh
10.0410.8611.68
Details
Intrinsic
Valuation
LowRealHigh
10.3311.1511.97
Details
Naive
Forecast
LowNextHigh
10.0010.8111.63
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
10.5610.8711.17
Details
Evaluating KP Tissue in context means comparing KP Tissue's to its competitive peer group. A company estimated as undervalued in absolute terms may be differently positioned when measured against sector-relative benchmarks.

Technical Indicators

KP Tissue Backtested Returns

KP Tissue registers a very low volatility profile across the specified investment window. It maintains a Sharpe Ratio (Efficiency) of 0.16, representing adjusted performance consistency. We identified twenty-nine technical indicators influencing the company's volatility profile. Please evaluate metrics such as standard deviation of 0.802, market risk-adjusted performance of 0.4985, and mean deviation of 0.5813 to validate implied downside exposure. KP Tissue has a performance score of 12 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.17, which means relatively modest fluctuations relative to the market. As returns on the market increase, KP Tissue's returns are expected to increase less than the market. However, during a bear market, the loss from holding KP Tissue is expected to be smaller as well. KP Tissue right now owns a risk of 0.82%. Please confirm KP Tissue potential upside, skewness, and the relationship between the sortino ratio and rate of daily change.
Auto-correlation
    
  0.07  

Virtually no predictability

Comparing KP Tissue's price behavior from 20th of December 2025 to 3rd of February 2026 with the period from 3rd of February 2026 to 20th of March 2026 produces virtually no predictability. The stronger the relationship between the current interval and its lagged values, the more accurately future price behavior of KP Tissue may be projected. The coefficient of 0.07 links barely 7.0% of KP Tissue's present price action to its own historical movements.
Correlation Coefficient0.07
Spearman Rank Test-0.22
Residual Average0.0
Price Variance0.07
Technical analysis for KP Tissue examines price and volume patterns over time. The approach includes tools such as moving averages and relative strength indicators.
The analysis looks at how KP Tissue price movement develops over time. Trend signals and pattern behavior define this framework. More Info...

Technical Analysis

Indicator
Time Period
Execute Indicator
This analysis covers thirty-seven data points across the selected time horizon. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of KP Tissue volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Technical Analysis Methodology & Indicators

Technical analysis of KP Tissue evaluates price structure, momentum, and volatility clustering. Breakout confirmation often requires sustained volume and liquidity depth. KP Tissue has a market cap of 101.78 M, ROE of 5.55%.

Unless otherwise specified, data for KP Tissue is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day.

This content is curated and reviewed by:

Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board
Last reviewed on March 9th, 2026

KP Tissue Technical Indicators

Technical analysis of KP Tissue is useful because it frames whether the current trend still looks durable or is beginning to weaken. Used correctly, technical indicators support timing and risk control but should still be validated against broader market and business context.

March 20, 2026 Daily Trend Indicators

Technical analysis of KP Tissue is useful because it frames whether the current trend still looks durable or is beginning to weaken. Used correctly, technical indicators support timing and risk control but should still be validated against broader market and business context.

More Resources for KPT Stock Analysis

Other Information on Investing in KPT Stock

Financial ratios represent how different financial values are linked for KP Tissue. They summarize how financial performance connects to valuation.